Business Context and Reporting Period
Company: TOMI Environmental Solutions, Inc. (TOMZ)
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended December 31, 2024
Business Overview: TOMI is a global provider of disinfection and decontamination solutions using its patented Binary Ionization Technology (BIT). The flagship product, SteraMist, utilizes ionized hydrogen peroxide (iHP) to eradicate pathogens in healthcare, life sciences, food safety, and commercial environments. The company operates as a single reportable segment.
Key Financial Metrics
| Metric | 2024 | 2023 |
|---|---|---|
| Net Revenue | $7,739,000 | $7,355,000 |
| Gross Profit | $3,557,000 | $4,290,000 |
| Gross Margin | 46% | 58% |
| Net Loss | $(4,477,000) | $(3,403,000) |
| Loss Per Share (Basic & Diluted) | $(0.22) | $(0.17) |
| Cash and Cash Equivalents (Year End) | $665,000 | $2,339,000 |
| Working Capital | $3,772,000 | $7,903,000 |
| Convertible Notes Payable (Net) | $2,361,000 | $2,298,000 |
| Accumulated Deficit | $(54,303,000) | $(49,826,000) |
Material Changes vs. Prior Period
- Revenue Growth: Net revenue increased by 5% ($384,000) driven by higher sales of mobile equipment and increased iHP service revenue. International revenue grew by $411,000, while U.S. revenue decreased slightly by $27,000.
- Margin Compression: Gross margin declined from 58% to 46%. This was primarily due to a $1,005,000 increase in the inventory reserve for slow-moving items and a $959,000 charge for expected credit losses included in General and Administrative expenses.
- Increased Loss: Net loss widened by approximately $1.1 million due to the aforementioned non-cash charges and increased interest expense ($389,000 in 2024 vs. $65,000 in 2023) related to convertible notes outstanding for the full year.
- Cost Reductions: Selling expenses decreased by 17% and R&D expenses decreased by 41% due to cost-cutting measures implemented in mid-2024, including executive compensation reductions and terminated consulting agreements.
Guidance, Outlook, Risks, and Contingencies
- Going Concern: The filing explicitly states there is substantial doubt about the company's ability to continue as a going concern within one year. This is due to recurring losses, negative cash flows from operations ($1.44 million used in 2024), and an accumulated deficit of $54.3 million.
- Liquidity Strategy: Management plans to fund operations through existing cash, cash generated from operations, and raising additional capital via equity or debt financings. In March/April 2025, the company sold $385,000 in convertible notes under a new $3 million facility.
- Nasdaq Compliance: On March 28, 2025, the company received a deficiency letter from Nasdaq for failing to maintain the minimum $1.00 bid price requirement. The company has 180 days (until September 24, 2025) to regain compliance or face delisting.
- Internal Controls: Management identified material weaknesses in internal controls over financial reporting as of December 31, 2024, citing limited resources with GAAP expertise and ineffective review policies.
- Outlook: The company anticipates growth from Custom Engineered Systems (CES) and Integrated Systems (SIS) installations, which drive recurring consumable sales. Early 2025 trends showed a 41% increase in iHP Corporate Service revenue compared to Q1 2024.
Investor Verification Checklist
- Cash Runway: Verify the sufficiency of the $665,000 cash balance against monthly burn rates given the "substantial doubt" going concern warning.
- Inventory Valuation: Scrutinize the $1.1 million inventory reserve and the $1.005 million charge taken in 2024 to ensure slow-moving stock is accurately assessed.
- Debt Obligations: Review the terms of the $2.6 million convertible notes (12% interest, $1.25 conversion price) and the new 2025 note issuance to assess dilution risk and interest burden.
- Nasdaq Status: Monitor the stock price to determine if the company can meet the $1.00 bid price requirement by September 2025 to avoid delisting.
- Internal Control Remediation: Assess the progress of remediation plans for the identified material weaknesses in financial reporting controls.